Catalyst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $13.11-$24.64 |
Market Cap | $2.6B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $460.4M |
Revenue Growth (YoY) | 25.3% |
Gross Profit (12 Mos) | $386.6M |
Diluted EPS | $1.18 |
News
See moreYahoo Finance • 10 days ago
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies
Yahoo Finance • 12 days ago
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
Yahoo Finance • 2 months ago
NewAmsterdam Pharma Stock Hits 90-Plus RS Rating
Yahoo Finance • 5 months ago
Despite lower earnings than three years ago, Catalyst Pharmaceuticals (NASDAQ:CPRX) investors are up 293% since then
About
CEO | Mr. Richard John Daly M.B.A. |
CFO | Mr. Michael W. Kalb CPA |
Address | 355 Alhambra Circle, Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 167 |
